Entrada Therapeutics Stock Price History

TRDA Stock  USD 12.12  0.10  0.83%   
If you're considering investing in Entrada Stock, it is important to understand the factors that can impact its price. As of today, the current price of Entrada Therapeutics stands at 12.12, as last reported on the 27th of February, with the highest price reaching 12.12 and the lowest price hitting 12.02 during the day. Entrada Therapeutics secures Sharpe Ratio (or Efficiency) of -0.22, which denotes the company had a -0.22 % return per unit of risk over the last 3 months. Entrada Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Entrada Therapeutics' Standard Deviation of 3.43, variance of 11.78, and Mean Deviation of 2.57 to check the risk estimate we provide.
  
At present, Entrada Therapeutics' Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 15.8 M, whereas Total Stockholder Equity is forecasted to decline to about 153.3 M. . At present, Entrada Therapeutics' Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0.76, whereas Price To Sales Ratio is forecasted to decline to 3.10. Entrada Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.2238

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsTRDA

Estimated Market Risk

 3.52
  actual daily
31
69% of assets are more volatile

Expected Return

 -0.79
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.22
  actual daily
0
Most of other assets perform better
Based on monthly moving average Entrada Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entrada Therapeutics by adding Entrada Therapeutics to a well-diversified portfolio.
Price Book
1.0736
Enterprise Value Ebitda
1.0685
Price Sales
2.1072
Shares Float
18.7 M
Wall Street Target Price
26.9275

Entrada Therapeutics Stock Price History Chart

There are several ways to analyze Entrada Stock price data. The simplest method is using a basic Entrada candlestick price chart, which shows Entrada Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceDecember 6, 202421.59
Lowest PriceFebruary 26, 202512.02

Entrada Therapeutics February 27, 2025 Stock Price Synopsis

Various analyses of Entrada Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Entrada Stock. It can be used to describe the percentage change in the price of Entrada Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Entrada Stock.
Entrada Therapeutics Price Action Indicator 0.10 
Entrada Therapeutics Price Daily Balance Of Power 1.00 
Entrada Therapeutics Price Rate Of Daily Change 1.01 

Entrada Therapeutics February 27, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Entrada Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Entrada Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Entrada Stock and then apply it to test your longer-term investment strategies against Entrada.

Entrada Stock Price History Data

The price series of Entrada Therapeutics for the period between Fri, Nov 29, 2024 and Thu, Feb 27, 2025 has a statistical range of 9.57 with a coefficient of variation of 18.86. The price distribution for the period has arithmetic mean of 15.87. The median price for the last 90 days is 17.1.
OpenHighLowCloseVolume
02/27/2025
 12.02  12.12  12.02  12.12 
02/26/2025 12.11  12.51  11.91  12.02  88,364 
02/25/2025 13.04  13.17  12.12  12.12  105,762 
02/24/2025 13.61  13.82  12.84  12.85  158,082 
02/21/2025 13.32  13.40  12.97  13.04  96,612 
02/20/2025 12.95  13.28  12.70  13.07  75,054 
02/19/2025 13.01  13.22  12.70  13.00  93,606 
02/18/2025 13.53  13.62  12.77  13.09  101,782 
02/14/2025 12.66  13.44  12.66  13.44  115,239 
02/13/2025 12.79  12.85  12.57  12.63  59,413 
02/12/2025 12.01  13.00  12.01  12.69  115,156 
02/11/2025 12.67  12.91  12.06  12.24  168,453 
02/10/2025 12.97  13.17  12.73  12.86  80,564 
02/07/2025 13.50  13.62  12.74  12.94  96,356 
02/06/2025 14.00  14.02  13.38  13.48  117,938 
02/05/2025 13.60  14.27  13.49  13.99  66,892 
02/04/2025 13.39  13.75  13.39  13.56  98,324 
02/03/2025 12.85  13.63  12.53  13.33  106,335 
01/31/2025 13.53  13.84  13.33  13.44  116,631 
01/30/2025 13.49  13.65  13.24  13.37  100,018 
01/29/2025 13.05  13.30  12.90  13.26  66,543 
01/28/2025 13.16  13.37  12.79  13.05  84,785 
01/27/2025 12.72  13.29  12.72  13.18  111,856 
01/24/2025 12.70  12.93  12.51  12.84  94,559 
01/23/2025 12.49  13.09  12.39  12.92  187,566 
01/22/2025 13.06  13.46  12.54  12.54  151,978 
01/21/2025 12.83  13.15  12.71  13.06  95,629 
01/17/2025 12.69  12.73  12.49  12.69  106,644 
01/16/2025 12.12  12.72  12.02  12.54  163,204 
01/15/2025 12.96  13.02  12.20  12.25  117,464 
01/14/2025 13.44  13.67  12.35  12.49  177,577 
01/13/2025 14.47  14.47  13.16  13.37  121,724 
01/10/2025 16.00  16.07  14.60  14.65  187,146 
01/08/2025 17.15  17.15  16.19  16.22  114,243 
01/07/2025 17.97  18.42  17.11  17.25  122,804 
01/06/2025 18.75  18.75  18.04  18.05  75,002 
01/03/2025 17.69  18.76  17.63  18.31  120,113 
01/02/2025 17.41  18.01  17.13  17.46  155,309 
12/31/2024 17.49  17.80  17.23  17.29  116,097 
12/30/2024 17.38  17.74  16.81  17.37  105,291 
12/27/2024 17.62  17.84  17.21  17.41  76,441 
12/26/2024 17.48  17.80  17.11  17.74  48,334 
12/24/2024 17.50  17.71  17.02  17.56  38,970 
12/23/2024 17.48  17.67  17.02  17.46  87,102 
12/20/2024 16.86  18.00  16.86  17.59  357,928 
12/19/2024 17.11  17.68  16.86  17.28  125,259 
12/18/2024 18.50  18.96  17.00  17.10  149,682 
12/17/2024 17.89  18.54  17.83  18.45  91,373 
12/16/2024 17.61  18.46  17.28  18.01  103,670 
12/13/2024 17.93  17.93  17.26  17.66  111,157 
12/12/2024 19.74  19.93  18.05  18.12  88,478 
12/11/2024 20.53  21.08  19.86  19.90  125,106 
12/10/2024 21.37  21.46  20.37  20.51  125,886 
12/09/2024 21.75  21.79  21.19  21.52  110,307 
12/06/2024 20.81  21.63  20.48  21.59  81,524 
12/05/2024 19.90  20.46  19.58  20.32  119,826 
12/04/2024 20.18  20.26  19.60  19.96  141,511 
12/03/2024 20.32  20.50  19.98  20.17  161,090 
12/02/2024 19.99  20.50  19.65  20.32  170,715 
11/29/2024 19.83  20.02  19.52  19.89  78,388 
11/27/2024 19.55  19.93  19.30  19.83  124,306 

About Entrada Therapeutics Stock history

Entrada Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entrada is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entrada Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entrada Therapeutics stock prices may prove useful in developing a viable investing in Entrada Therapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding38 M34.8 M
Net Loss-85.2 M-80.9 M

Entrada Therapeutics Quarterly Net Working Capital

394.73 Million

Entrada Therapeutics Stock Technical Analysis

Entrada Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Entrada Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Entrada Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run ETF Categories Now

   

ETF Categories

List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
All  Next Launch Module

Entrada Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Entrada Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Entrada Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Entrada to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Entrada Stock analysis

When running Entrada Therapeutics' price analysis, check to measure Entrada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entrada Therapeutics is operating at the current time. Most of Entrada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Entrada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entrada Therapeutics' price. Additionally, you may evaluate how the addition of Entrada Therapeutics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets